Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 13.53 is 24% above its 2-year average of 10.95, around the middle of its 2-year range (0.00–23.99).
As of the fiscal period ended Tuesday, June 30, 2026. 46.21% above its 12-month average of 9.25.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.53.
CURRENT RATIO
13.53
CURRENT RATIO AVG TTM
9.25
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+46.21%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+260.81%
vs the sector median at left
Polaryx Therapeutics, Inc. Common Stock
Market Cap
$103.68M
Current Ratio
13.53
TTM Avg
9.25
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.00M
Current Ratio
7.28
TTM Avg
6.67
3Y Avg
7.13
5Y Avg
10.02
Market Cap
$104.21M
Current Ratio
1.86
TTM Avg
1.97
3Y Avg
2.28
5Y Avg
2.24
Market Cap
$102.92M
Current Ratio
8.54
TTM Avg
8.31
3Y Avg
10.99
5Y Avg
13.36
Market Cap
$105.93M
Current Ratio
0.96
TTM Avg
1.08
3Y Avg
1.26
5Y Avg
1.56
Market Cap
$106.33M
Current Ratio
5.71
TTM Avg
10.50
3Y Avg
6.63
5Y Avg
5.88
Market Cap
$107.43M
Current Ratio
0.81
TTM Avg
0.51
3Y Avg
0.77
5Y Avg
1.23
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polaryx Therapeutics, Inc. Common Stock (PLYX) | $103.68M | 13.53 | 9.25 | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | 7.28 | 6.67 | 7.13 | 10.02 |
| Definitive Healthcare Corp. (DH)vs › | $104.21M | 1.86 | 1.97 | 2.28 | 2.24 |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.92M | 8.54 | 8.31 | 10.99 | 13.36 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $105.93M | 0.96 | 1.08 | 1.26 | 1.56 |
| The Joint Corp. (JYNT)vs › | $101.28M | 1.83 | 1.56 | 1.30 | 1.30 |
| Immunic, Inc. (IMUX)vs › | $106.18M | 5.05 | 1.26 | 3.56 | 6.57 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.33M | 5.71 | 10.50 | 6.63 | 5.88 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $107.43M | 0.81 | 0.51 | 0.77 | 1.23 |
| Vivani Medical, Inc. (VANI)vs › | $108.23M | 3.25 | 3.06 | 4.28 | 3.23 |
Current Ratio
13.53
Quick Ratio
13.53
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 13.53 |
| 2026-03-31 | 3.45 |
| 2025-12-31 | 8.55 |
| 2025-09-30 | 8.77 |
| 2025-06-30 | 11.97 |
| 2025-03-31 | 23.99 |
| 2024-12-31 | 17.30 |
| 2024-09-30 | 0.00 |
